These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8519018)

  • 1. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure].
    Hoyen HA; Alpert JS
    Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ
    Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].
    Drexler H
    Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors. Pharmacological and physiological background for cardiovascular treatment.
    Jerie P
    Cor Vasa; 1992; 34(1):31-66. PubMed ID: 1288942
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormones and hemodynamics in heart failure.
    Schrier RW; Abraham WT
    N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Future aspects of therapy with diuretics].
    Düsing R
    Internist (Berl); 1992 Aug; 33 Suppl 1():S53-6. PubMed ID: 1428699
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical pharmacology of angiotensin II antagonists].
    Arabidze GG; Novikova LS
    Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system in hypertension: an update.
    Brunner HR
    Hosp Pract (Off Ed); 1990 Aug; 25(8):71-81. PubMed ID: 2116434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The renin-angiotensin system:implications, pathology, therapeutic possibilities, perspectives].
    Ionescu SD; Sandru V; Burdujan A; Tovarniţchi S
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):669-73. PubMed ID: 12092217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients.
    Schneeweiss A
    Pediatr Cardiol; 1990 Oct; 11(4):199-207. PubMed ID: 2274447
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860
    [No Abstract]   [Full Text] [Related]  

  • 18. Converting enzyme inhibitors in heart failure.
    Nicholls MG; Ikram H; Fitzpatrick MA; Crozier IG
    Eur Heart J; 1988 Jun; 9 Suppl H():77-83. PubMed ID: 3049097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function].
    Osterziel KJ; Dietz R; Kübler W
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1082-5. PubMed ID: 2661192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.